The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Procept BioRobotics Corp shares valued at $2,062,679 were sold by Waters Kevin on Sep 16 ’24. At $82.51 per share, Waters Kevin sold 25,000 shares. The insider’s holdings dropped to 96,096 shares worth approximately $6.95 million following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Kevin Waters purchased 50,000 shares, netting a total of over 4,055,500 in proceeds.
Before that, Desai Antal Rohit had sold 44,867 shares from its account. In a trade valued at $3,594,377, the Director traded Procept BioRobotics Corp shares for $80.11 each. Upon closing the transaction, the insider’s holdings decreased to 44,867 shares, worth approximately $14.28 million.
As published in their initiating research note from Piper Sandler on August 11, 2023, Procept BioRobotics Corp [PRCT] has been an Overweight and the price target has been revised to $42. Analysts at William Blair started covering the stock with ‘”an Outperform”‘ outlook in a report released in late May. As of October 31, 2022, BTIG Research has initiated its “Neutral” rating for PRCT. Earlier on October 25, 2022, Truist initiated its rating. Their recommendation was “a Buy” for PRCT stock.
Analyzing PRCT Stock Performance
During the last five days, there has been a drop of approximately -2.69%. Over the course of the year, Procept BioRobotics Corp shares have jumped approximately 72.54%. Shares of the company reached a 52-week high of $85.81 on 08/21/24 and a 52-week low of $39.48 on 01/05/24. A 50-day SMA is recorded $73.74, while a 200-day SMA reached $59.78. Nevertheless, trading volume fell to 0.62 million shares from 0.64 million shares the previous day.
Support And Resistance Levels for Procept BioRobotics Corp (PRCT)
According to the 24-hour chart, there is a support level at 71.28, which, if violated, would cause prices to drop to 70.24. In the upper region, resistance lies at 73.96. The next price resistance is at 75.61. RSI (Relative Strength Index) is 42.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.73, which suggests the price will decrease in the coming days. Percent R is at 80.27%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
